Global Liquid Biopsy Industry Market Research Report 2019

Published Date: 2019-02-07   |   Pages: 108   |   Tables: 115   | Report Id: 980982   | Hits: 76 |   Medical Devices & Consumables

category cover

Increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D are some of the key factors driving the growth of the market.

The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

The global Liquid Biopsy market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Liquid Biopsy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Liquid Biopsy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:



Roche Diagnostics

Bio-Rad Laboratories

Myriad Genetics

Menarini-Silicon Biosystems


Guardant Health


Genomic Health

Raindance Technologies

Thermo Fisher Scientific


Segment by Regions

North America




Segment by Type

Test Suite



Segment by Application

Reference Laboratory

The Hospital

Research Center


Licenses Type

Only one user can access the report
Multiple users can access the report


 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Liquid Biopsy Industry market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...